Aziyo Biologics AZYO
$ 1.48
1.37%
Quarterly report 2024-Q3
added 11-14-2024
Country |
USA |
IPO year |
2020 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Ronald K. Lloyd |
Employees in the company |
156 |
Shares |
18.2 M |
Market Cap[1] |
$ 20.5 M |
EBITDA (LTM) |
$ -31.2 M |
P/E (LTM) |
-0.61 |
P/S (LTM) |
0.82 |
EPS (LTM) |
-2.42 |
Other stocks of industry "Medical devices"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.